Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

693
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
693
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

342
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
342
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

262
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
262
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

663
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
663

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Heat shock factor-1 alleviates ER-stress in Caenorhabditis elegans.

Scientific reports·2026
Same author

Heat shock factor-1 alleviates ER-stress in Caenorhabditis elegans.

Scientific reports·2026
Same author

Photoinduced Spin Polarization of a Gadolinium Complex.

Journal of the American Chemical Society·2026
Same author

Rethinking smoking cessation guidelines in patients with obstructive sleep apnoea: a survey of sleep experts from the ESADA network.

The European respiratory journal·2026
Same author

Correction: Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependencies.

Leukemia·2026
Same author

The impact of paediatric periodic limb movement disorder and obstructive sleep apnoea syndrome on sleep quality and daytime symptoms.

Sleep & breathing = Schlaf & Atmung·2026

Related Experiment Video

Updated: Mar 13, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K

Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea.

Laszlo Kunos1, Zsofia Lazar1, Fruzsina Martinovszky1

  • 1Department of Pulmonology, Semmelweis University, 1/C Dios arok, Budapest, 1125, Hungary.

Lung
|October 23, 2016
PubMed
Summary

Obstructive sleep apnoea (OSA) causes diurnal lung function changes, with FEV1 increasing overnight in patients. This finding highlights the importance of considering measurement timing for pulmonary function tests in OSA.

Keywords:
Forced expiratory volume in 1 sLung functionObstructive sleep apnoeaOvernight changes

More Related Videos

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.8K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.7K

Related Experiment Videos

Last Updated: Mar 13, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.8K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.7K

Area of Science:

  • Pulmonary Medicine
  • Sleep Medicine
  • Respiratory Physiology

Background:

  • Obstructive sleep apnoea (OSA) is a common condition characterized by upper airway collapse during sleep.
  • The effects of sleep-disordered breathing on pulmonary function indices are not well understood.
  • Understanding these effects is crucial for comprehensive patient management.

Purpose of the Study:

  • To investigate diurnal variations in lung function indices in patients with OSA.
  • To correlate pulmonary function changes with the severity of OSA.
  • To assess if sleep-disordered breathing impacts lung function measurements.

Main Methods:

  • A cohort of 42 OSA patients and 73 healthy controls were studied.
  • Participants underwent clinical and spirometric assessments to exclude asthma and COPD.
  • Spirometry was performed in the evening and morning after polysomnography.

Main Results:

  • No significant difference in evening or morning FEV1 or FVC between OSA patients and controls.
  • FEV1 significantly increased from evening to morning in OSA patients, while FVC remained unchanged.
  • Overnight FEV1 increase in OSA was associated with male gender, obesity, and lack of statin or beta-blocker treatment.

Conclusions:

  • Diurnal variations in spirometric indices, specifically an overnight increase in FEV1, occur in OSA patients.
  • These FEV1 changes are independent of FVC variations and correlate with OSA severity.
  • The timing of lung function measurements should be considered in patients with OSA.